The civic record
Read. Follow. Verify.Senate Hearing on Gene Editing Technology: Innovation and Impact
Record date · January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This document is a transcript from a 2017 Senate Health, Education, Labor, and Pensions Committee hearing regarding the potential and ethical implications of gene-editing technologies like . Experts and lawmakers discussed how these tools can be used to treat diseases, their accessibility compared to older methods, and the broader societal impacts of genetic modification.
The hearing explores the regulatory and ethical landscape for technology, which could fundamentally change how medical conditions like sickle cell anemia are treated in the future.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Medical Research Community
Researchers utilize CRISPR as a primary tool for genetic experimentation and disease treatment development.
Agricultural Industry
The industry uses gene-editing technology to develop crops with specific traits, such as disease resistance.
Patients with Genetic Diseases
Individuals with conditions like sickle cell anemia are the potential recipients of therapies developed through gene-editing research.
Key Facts
- CRISPR technology functions by using molecules to locate, cut, and edit specific genes, similar to a 'cut and paste' function in a computer document.
- CRISPR was developed in 1993 and perfected for human application in 2013.
- CRISPR is noted for being less expensive, more precise, and more accessible to global scientists than previous gene-editing methods.
- The technology has been applied to agriculture to create disease-resistant wheat and rice.
Show all 6 facts
- Medical research applications include potential treatments for sickle cell anemia.
- The hearing included testimony from experts in pediatrics, biotechnology, and bioethics.
Frequently Asked Questions
What is CRISPR?
How is CRISPR different from older gene-editing tools?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Early Congressional Interest in CRISPR
The hearing demonstrates that as early as 2017, the Senate was actively engaging with the ethical and practical implications of CRISPR, signaling a proactive approach to emerging biotech regulation.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools